<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">In order to elicit specific immunological memory against known cancer epitopes, Efferson et al. established a combined strategy of oncolytic influenza A viruses armed with a vaccination peptide against the human epidermal growth factor receptor 2 (HER2)
 <sup>
  <xref ref-type="bibr" rid="CR97">97</xref>
 </sup>. This approach led to potent initiation of effector and memory T cells in an in vitro DC-based assay.
</p>
